title: [Management of multiple myeloma in Hungary in 2016].
abstract: The last decade has witnessed a dramatic progress in the treatment of multiple myeloma. Both the chemotherapy protocols and the supportive therapy options have improved significantly since the publication of the previous Hungarian national guideline. An increasing proportion of patients now reach a durable response and cure became a potential option for some. The aim of the authors was to adapt the international guidelines to the specific circumstances of the Hungarian healthcare system in the light of the most recent developments.
authors.affiliation: III. Belgyógyászati Klinika, Haematológiai részleg, Semmelweis Egyetem, Általános Orvostudományi Kar Budapest, Kútvölgyi út 4., 1125.
authors.forename: Gergely
authors.initials: G
authors.lastname: Varga
authors.affiliation: Hematológiai és Őssejt-transzplantációs Osztály, Egyesített Szent István és Szent László Kórház-Rendelőintézet Budapest.
authors.forename: Gábor
authors.initials: G
authors.lastname: Mikala
authors.affiliation: Belgyógyászati Intézet, Hematológiai Tanszék, Debreceni Egyetem, Általános Orvostudományi Kar Debrecen.
authors.forename: László
authors.initials: L
authors.lastname: Váróczy
authors.affiliation: Belgyógyászati Intézet, Hematológiai Tanszék, Debreceni Egyetem, Általános Orvostudományi Kar Debrecen.
authors.forename: Árpád
authors.initials: Á
authors.lastname: Illés
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002985:Clinical Protocols; D004164:Diphosphonates / Q000008:administration & dosage; D004334:Drug Administration Schedule; D004921:Erythropoietin / Q000008:administration & dosage; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D006814:Hungary; D009101:Multiple Myeloma / Q000175:diagnosis* / Q000628:therapy*; D017410:Practice Guidelines as Topic
chemical_list: D004164:Diphosphonates; D004921:Erythropoietin; D016179:Granulocyte Colony-Stimulating Factor
keywords: autologous stem cell transplantation; autológ őssejt-transzplantáció; bortezomib; guideline; irányelv; lenalidomid; lenalidomide; multiple myeloma; myeloma multiplex